Wellington, New Zealand

David Francis Ackerley

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2010-2020

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: **David Francis Ackerley: Innovator in Biochemical Detection Methods**

Introduction

David Francis Ackerley is a prominent inventor based in Wellington, New Zealand. With a portfolio that includes eight patents, Ackerley has made significant contributions to the fields of biochemistry and diagnostics. His innovative work primarily focuses on the detection and measurement of critical biomolecules, making strides in both medical and industrial applications.

Latest Patents

Among Ackerley's latest inventions are two notable patents that underline his expertise. The first patent involves methods for detecting and measuring glutamine and its analogues. This innovation provides methods for assessing glutamine levels, which is vital for various diagnostic applications. Moreover, it outlines the use of glutamine analogues in synthesizing colored pigments and other beneficial agents through nonribosomal peptide synthetase (NRPS).

The second patent revolves around bacterial nitroreductase enzymes and their diverse methods of use. This invention highlights the potential for non-invasive imaging techniques, monitoring therapeutic cell populations, and gene-directed enzyme prodrug therapy. Additionally, it focuses on the application of these enzymes in radioimaging and the ablation of biological agents, showcasing the versatility and importance of his research.

Career Highlights

David Ackerley's career has seen him interact with several reputable organizations. Notably, he has contributed to Health Innovation Ventures BV and Victoria Link Limited, where his skills and inventions have facilitated advancements in health technologies and innovations. His ingenuity continues to shape the landscape of biochemical research and applications.

Collaborations

Throughout his career, Ackerley has worked collaboratively with esteemed colleagues, including Jeffrey Bruce Smaill and Adam Vorn Patterson. These collaborations have fostered an environment of innovation and creative problem-solving, resulting in breakthrough research and patented technologies.

Conclusion

David Francis Ackerley's contributions to innovation in biochemical detection are noteworthy. With a focus on glutamine detection methods and bacterial enzyme applications, he remains a vital figure in advancing techniques that have significant implications in both healthcare and industry. His continued work promises to yield further advancements, reflecting his dedication to improving scientific methodologies and understanding.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…